-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Alnylam Pharmaceuticals, Inc. annual Depreciation history and growth rate from 2010 to 2023.
- Alnylam Pharmaceuticals, Inc. annual Depreciation for 2023 was $51.6M, a 32% increase from 2022.
- Alnylam Pharmaceuticals, Inc. annual Depreciation for 2022 was $39.1M, a 6.25% increase from 2021.
- Alnylam Pharmaceuticals, Inc. annual Depreciation for 2021 was $36.8M, a 21.9% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)